How to Taper Off Fludrocortisone for Orthostatic Hypotension
There is no established tapering protocol for fludrocortisone in orthostatic hypotension; based on available evidence, the medication can be discontinued abruptly without a formal taper when clinically appropriate.
Evidence for Discontinuation Strategy
The FDA labeling for fludrocortisone provides no specific tapering instructions for discontinuation 1. Unlike glucocorticoids, which require tapering to prevent adrenal insufficiency, fludrocortisone is a pure mineralocorticoid and does not suppress the hypothalamic-pituitary-adrenal axis when used for orthostatic hypotension.
The most relevant clinical evidence comes from a case report where fludrocortisone was successfully discontinued without tapering and without return of orthostatic symptoms 2. In this case, a patient initially on fludrocortisone 0.3 mg daily had the dose reduced to 0.1 mg twice daily, then later discontinued entirely with no recurrence of hypotension or orthostatic symptoms.
Practical Approach to Discontinuation
When discontinuing fludrocortisone for orthostatic hypotension:
- Monitor for symptom recurrence: Watch for return of dizziness, lightheadedness, or syncope
- Check orthostatic vital signs: Measure blood pressure supine and after 1-3 minutes of standing before and after discontinuation
- Consider dose reduction first (optional, not required): If concerned about abrupt discontinuation, you may reduce from standard doses (0.1-0.2 mg daily) to 0.05 mg daily for several days before stopping 1
- Ensure adequate hydration and salt intake: Maintain non-pharmacological measures (increased fluid intake to 2-3 L daily, salt supplementation 6-10 g daily)
Important Caveats
Do not confuse this with Addison's disease or adrenal insufficiency, where fludrocortisone is used as hormone replacement therapy. In those conditions, fludrocortisone should never be abruptly discontinued as it provides essential mineralocorticoid replacement 1.
The decision to discontinue should be based on:
- Resolution of underlying cause of orthostatic hypotension
- Adequate symptom control with non-pharmacological measures alone
- Development of intolerable side effects (hypertension, edema, hypokalemia) 3, 1
Monitor serum potassium after discontinuation if the patient was on fludrocortisone long-term, as chronic use can cause hypokalemia that may normalize after stopping 3.